Tariq Arshad - 08 Dec 2021 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QLGN	Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	08 Dec 2021	Common Stock	300,000	$1.24	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Shares underlying the stock option vest over two-plus years in three equal annual installments from the vesting commencement date of May 17, 2021.